Welsh, Carson, Anderson & Stowe to Acquire EquiLend

Published on January 18, 2024

Welsh, Carson, Anderson & Stowe to Acquire EquiLend

Continue reading on website
Other news

Blog: How does AbZelect™ improve cell line development productivity?

January 17, 2024
How does AbZelect™ improve cell line development productivity? A Q&A with Simon KeenCould you provide an overview of the AbZelect™ and AbZelectPRO™ platforms? AbZelect™ and AbZelectPRO™ are cell line development (CLD) platforms that enable the rapid generation and selection of high-yielding mammalian Chinese hamster ovary (CHO) cell lines for therapeutic protein and recombinant vaccine production.

Webinar: Leveraging Advanced Analytical Technologies for ADCs

January 18, 2024
Abzena & Waters Webinar: Leveraging Advanced Analytical Technologies to Expedite the Development of Antibody Drug ConjugatesFebruary 28th, 2024 at 8am PST / 11am EST / 4pm GMTSpeakers:Eric Miller, Ph.D., Sr. Scientific Leader for Analytical Development at AbzenaColette Quinn, PhD, Director of Marketing and Strategy at Waters|Wyatt TechnologyRegister Here!Overview:A critical step in the development